CXDO vs. SURG, ATNI, SILC, SANG, PXLW, KEQU, SATL, XNET, GSIT, and ELVA
Should you be buying Crexendo stock or one of its competitors? The main competitors of Crexendo include SurgePays (SURG), ATN International (ATNI), Silicom (SILC), Sangoma Technologies (SANG), Pixelworks (PXLW), Kewaunee Scientific (KEQU), Satellogic (SATL), Xunlei (XNET), GSI Technology (GSIT), and Electrovaya (ELVA). These companies are all part of the "computer and technology" sector.
SurgePays (NASDAQ:SURG) and Crexendo (NASDAQ:CXDO) are both small-cap computer and technology companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, profitability, risk and institutional ownership.
SurgePays has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Crexendo has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500.
SurgePays has higher revenue and earnings than Crexendo. Crexendo is trading at a lower price-to-earnings ratio than SurgePays, indicating that it is currently the more affordable of the two stocks.
In the previous week, Crexendo had 7 more articles in the media than SurgePays. MarketBeat recorded 11 mentions for Crexendo and 4 mentions for SurgePays. SurgePays' average media sentiment score of 0.23 beat Crexendo's score of 0.00 indicating that Crexendo is being referred to more favorably in the news media.
SurgePays received 157 more outperform votes than Crexendo when rated by MarketBeat users. Likewise, 68.72% of users gave SurgePays an outperform vote while only 38.46% of users gave Crexendo an outperform vote.
6.9% of SurgePays shares are owned by institutional investors. Comparatively, 9.5% of Crexendo shares are owned by institutional investors. 29.4% of SurgePays shares are owned by company insiders. Comparatively, 56.6% of Crexendo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
SurgePays has a net margin of 15.03% compared to SurgePays' net margin of -0.68%. Crexendo's return on equity of 104.66% beat SurgePays' return on equity.
SurgePays currently has a consensus target price of $10.00, suggesting a potential upside of 144.50%. Crexendo has a consensus target price of $6.38, suggesting a potential upside of 56.63%. Given Crexendo's higher possible upside, equities analysts clearly believe SurgePays is more favorable than Crexendo.
Summary
SurgePays beats Crexendo on 10 of the 18 factors compared between the two stocks.
Get Crexendo News Delivered to You Automatically
Sign up to receive the latest news and ratings for CXDO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CXDO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Crexendo Competitors List
Related Companies and Tools
